BioLight Life Sciences Ltd (TA:BOLT) — Stock Price
BioLight Life Sciences Ltd (TA:BOLT) is currently trading at ILA347.00 ILA, down 1.98% today. Over the past 52 weeks, shares have ranged between ILA217.90 and ILA542.10. This page tracks BioLight Life Sciences Ltd's live share price on the TA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BioLight Life Sciences Ltd stock valuation.
BioLight Life Sciences Ltd (BOLT) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BioLight Life Sciences Ltd's daily closing share price and trading volume on the TA exchange over the past year, giving a clear view of recent price momentum and liquidity.
BioLight Life Sciences Ltd Income Statement — Revenue, Profit & Earnings by Year
BioLight Life Sciences Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | ILA0.00 | ILA219.00K | ILA118.00K | ILA63.00K | ILA3.00K |
| Cost of Revenue | ILA544.00K | ILA595.00K | — | ILA588.00K | ILA532.00K |
| Gross Profit | ILA-544.00K | ILA219.00K | ILA118.00K | ILA63.00K | ILA3.00K |
| Research & Development | ILA4.82 Million | ILA3.67 Million | ILA4.52 Million | ILA3.53 Million | ILA4.33 Million |
| SG&A | ILA6.52 Million | ILA2.49 Million | ILA5.63 Million | ILA1.96 Million | ILA2.05 Million |
| Total Operating Expenses | ILA14.66 Million | ILA7.82 Million | ILA26.69 Million | ILA8.76 Million | ILA535.00K |
| Operating Income | ILA-15.21 Million | ILA-7.60 Million | ILA-26.57 Million | ILA-8.70 Million | ILA-532.00K |
| EBITDA | ILA-14.66 Million | ILA-7.75 Million | ILA-10.60 Million | ILA-8.03 Million | ILA-1.31 Million |
| EBIT | ILA-15.21 Million | ILA-8.34 Million | ILA-10.65 Million | ILA-8.62 Million | ILA-1.89 Million |
| Interest Expense | ILA92.00K | ILA94.00K | ILA77.00K | ILA80.00K | ILA74.00K |
| Income Before Tax | ILA-16.91 Million | ILA-8.42 Million | ILA-27.49 Million | ILA-8.69 Million | ILA-1.91 Million |
| Income Tax Expense | — | — | — | — | ILA-1.57 Million |
| Net Income | ILA-11.73 Million | ILA-7.14 Million | ILA-26.02 Million | ILA-7.85 Million | ILA382.00K |
BioLight Life Sciences Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BioLight Life Sciences Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | ILA42.41 Million | ILA34.12 Million | ILA33.45 Million | ILA57.01 Million | ILA64.17 Million |
| Total Current Assets | ILA24.40 Million | ILA14.35 Million | ILA9.06 Million | ILA18.02 Million | ILA34.00 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | ILA19.68 Million | ILA3.75 Million | ILA250.00K | ILA4.23 Million | ILA245.00K |
| Net Receivables | ILA307.00K | ILA435.00K | ILA754.00K | ILA307.00K | ILA253.00K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | — | — | — | ILA3.34 Million | ILA3.26 Million |
| Goodwill | ILA686.00K | — | — | — | ILA112.00K |
| Total Liabilities | ILA2.24 Million | ILA3.38 Million | ILA3.15 Million | ILA3.32 Million | ILA2.75 Million |
| Total Current Liabilities | ILA2.00 Million | ILA2.07 Million | ILA2.31 Million | ILA2.54 Million | ILA2.21 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | ILA-3.21 Million | ILA-9.12 Million | ILA-5.18 Million | ILA-12.87 Million | ILA-33.02 Million |
| Total Stockholder Equity | ILA34.40 Million | ILA26.88 Million | ILA29.78 Million | ILA53.17 Million | ILA60.70 Million |
| Retained Earnings | ILA-261.69 Million | ILA-249.97 Million | ILA-242.82 Million | ILA-216.80 Million | ILA-208.96 Million |
BioLight Life Sciences Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BioLight Life Sciences Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ILA-10.85 Million | ILA-10.99 Million | ILA-9.58 Million | ILA-9.54 Million | ILA-10.03 Million |
| Capital Expenditures | ILA5.00K | ILA28.00K | ILA1.42 Million | ILA98.00K | ILA626.00K |
| Free Cash Flow | ILA-10.86 Million | ILA-11.02 Million | ILA-10.99 Million | ILA-9.64 Million | ILA-10.65 Million |
| Investing Cash Flow | ILA-16.17 Million | ILA7.55 Million | ILA-1.95 Million | ILA-10.55 Million | ILA13.48 Million |
| Financing Cash Flow | ILA21.37 Million | ILA7.98 Million | ILA3.25 Million | ILA-485.00K | ILA915.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | ILA3.91 Million | ILA382.00K | ILA54.00K | ILA315.00K | ILA332.00K |
| Depreciation | ILA544.00K | ILA595.00K | ILA574.00K | ILA588.00K | ILA532.00K |
| Change in Cash | ILA-5.74 Million | ILA4.44 Million | ILA-8.12 Million | ILA-20.07 Million | ILA3.48 Million |
BioLight Life Sciences Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track BioLight Life Sciences Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 08, 2025 | — | — | — |
| Dec 01, 2015 | -0.39 | -0.75 | +48.00% |
| Aug 31, 2015 | -0.81 | -0.75 | -8.00% |
| Jun 01, 2015 | -0.64 | -0.50 | -28.00% |
| Nov 30, 2014 | -0.64 | — | — |